FDA Issues Update on Propofol Shortage
(February 26, 2010)
On February 24, 2010, the Food and Drug Administration (FDA) posted updated information regarding the availability of propofol on its website.
In summary, APP, one of the manufacturers of propofol, is launching an FDA approved generic version of propofol (10 mg/ml injection) that should help alleviate the shortages. With the availability of this new product, importation and distribution of Propoven 1% (propofol 1%) from APP will be suspended. Meanwhile, the other two other manufacturers, Teva and Hospira, are back online and are working to restore availability to meet market demand.
For complete details of this announcement, please visit the FDA’s website
ASA will continue to work closely with the FDA to ensure that necessary anesthesia drugs remain readily available. If you or your facility are experiencing difficulty obtaining any drug, please contact the FDA’s drug shortage group at email@example.com.
THE AMERICAN SOCIETY OF ANESTHESIOLOGISTS
Anesthesiologists: Physicians providing the Lifeline of Modern Medicine TM. Founded in 1905, the American Society of Anesthesiologists is an educational, research and scientific association with more than 50,000 members organized to raise and maintain the standards of the medical practice of anesthesiology and improve the care of the patient.
For more information on the field of anesthesiology, visit the American Society of Anesthesiologists website at www.asahq.org.
For patient information, visit